Showa Denko Introduces UBIC’s “PATENT EXPLORER”

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Showa Denko Introduces UBIC’s “PATENT EXPLORER” Intellectual Property Strategy Support System

TOKYO, Dec. 24, 2015 (GLOBE NEWSWIRE) -- UBIC, Inc. (Nasdaq: UBIC ) (TSE: 2158 ), a leading provider of international litigation support and big-data analysis services, announced today that Lit i View PATENT EXPLORER was introduced by Showa Denko K.K. in December 2015. Lit i View PATENT EXPLORER is an intellectual property strategy support system that uses UBIC’s proprietary “KIBIT” artificial intelligence (AI) engine.

On October 29, 2015, UBIC launched PATENT EXPLORER, which was commercialized based on the results of a joint development project undergone by UBIC and Toyota Technical Development Corporation. This system significantly improves the efficiency of patent analysis work, including prior art search and invalidity research. Specifically, it increases the efficiency by a factor of around 330 when compared with conventional research techniques. Data concerning the specifics of relevant documents (invention proposals, documents related to patents targeted for invalidation, etc.) is fed into the KIBIT AI engine as “teaching data.” Using a machine learning technique called “landscaping,” the system analyzes a vast volume of data based on a small volume of teaching data and sorts documents by relevancy in a short period of time.

Showa Denko is a major Japanese chemical manufacturer whose product lineup includes petrochemicals, chemicals, electronics products, inorganic materials and aluminum. The company regards intellectual property strategy as critical to its growth and development amid global competition.

Showa Denko quickly decided to introduce PATENT EXPLORER, as it is eager to benefit from the technology’s advanced intellectual property analysis. A trial period has demonstrated PATENT EXPLORER’s higher research efficiency compared with conventional research techniques, such as keyword-based search, similarity search and concept search, as well as its superiority in terms of the accuracy and comprehensiveness of analysis.

Since launching PATENT EXPLORER, UBIC has received numerous inquiries about the product and trial introductions. At the 2015 Patent Information Fair & Conference held on November 2 - 4, UBIC’s booth and presentation drew more visitors than expected and the number of companies which are committing to use the product on a trial basis has steadily increased. In December, one more company decided to introduce PATENT EXPLORER, with more intellectual property and research and development divisions of companies expected to follow suit in the future.

About UBIC, Inc.

UBIC, Inc. (Nasdaq: UBIC ) (TSE: 2158 ) supports the analysis of big data based on behavior informatics by utilizing its technology, "KIBIT". UBIC's KIBIT technology is driven by UBIC AI based on knowledge acquired through its litigation support services. The KIBIT incorporates experts' tacit knowledge, including their experiences and intuitions, and utilizes that knowledge for big data analysis. UBIC continues to expand its business operations by applying KIBIT to new fields such as healthcare and marketing.UBIC was founded in 2003 as a provider of e-discovery and international litigation support services. These services include the preservation, investigation and analysis of evidence materials contained in electronic data, and computer forensic investigation. UBIC provides e-discovery and litigation support by making full use of its data analysis platform, "Lit i View ® ", and its Predictive Coding technology adapted to Asian languages.

For more information about UBIC, contact usinfo@ubicna.com or visit http://www.ubic-global.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the amount of data that UBIC expects to manage this year and the potential uses for UBIC's new service in intellectual property-related litigation, contain forward-looking statements. UBIC may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about UBIC's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: UBIC's goals and strategies; UBIC's expansion plans; the expected growth of the data center services market; expectations regarding demand for, and market acceptance of, UBIC's services; UBIC's expectations regarding keeping and strengthening its relationships with customers; UBIC's plans to invest in research and development to enhance its solution and service offerings; and general economic and business conditions in the regions where UBIC provides solutions and services. Further information regarding these and other risks is included in UBIC's reports filed with, or furnished to the Securities and Exchange Commission. UBIC does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of the date of this press release, and UBIC undertakes no duty to update such information, except as required under applicable law.

UBIC Global PR UBIC North America, Inc. Tel: (212) 924-8242 global_pr@ubic.co.jp

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Shareholder Investigations in Various Companies

Updated Category News Views 261

Overview of Current Shareholder Investigations Brodsky & Smith, a well-known litigation law firm, is actively reminding shareholders about various ongoing investigations involving Sealed Air Corporation, Movano Inc., Gulf Island Inc., and Denny's Corporation. If you are a shareholder interested in obtaining more information regarding these investigations, you can reach...

Continue Reading
Nykredit Announces Voluntary Tender Offer for Spar Nord Bank

Updated Category News Views 147

Nykredit Announces a Voluntary Public Tender Offer for Spar Nord Bank Nykredit Realkredit A/S, a prominent player in the Danish financial landscape, has publicly unveiled its plans for a voluntary tender offer directed at Spar Nord Bank A/S. This anticipated offer, which signals Nykredit's strategic expansion ambitions, seeks to acquire all available shares in Spar Nord...

Continue Reading
Big 5 Sporting Goods Embarks on New Growth Journey After Merger

Updated Category News Views 292

Big 5 Sporting Goods Corporation Announces Merger Completion Big 5 Sporting Goods Corporation (Nasdaq: BGFV), a well-established name in the sporting goods industry, has successfully completed its merger with a partnership composed of Worldwide Golf and Capitol Hill Group. This new chapter for Big 5 is expected to propel the company towards greater heights. Merger Details...

Continue Reading
UCB's BIMZELX® Data: A Game Changer for Arthritis Care

Updated Category News Views 132

UCB's Innovative Efforts in Arthritis Treatment UCB is making significant strides in the field of rheumatology, particularly with the release of new data regarding BIMZELX® (bimekizumab-bkzx) presented at the ACR Convergence 2024. This marks the first time the company has shared data specifically relating to psoriatic arthritis (PsA), non-radiographic axial...

Continue Reading
Mega Matrix Launches Captivating Urban Romance on FlexTV

Updated Category News Views 614

Engaging Romance Premieres on FlexTV Mega Matrix Inc. (NYSE American: MPU) has unveiled a captivating romantic miniseries titled A flash Marriage With The Billionaire Tycoon, streaming on its renowned short series platform, FlexTV. This adventurous drama dives into themes of love, responsibility, and the quest for personal redemption, showcasing the complicated lives of...

Continue Reading